Search hospitals > New Jersey > New Brunswick
Saint Peter's University Hospital
Claim this profileNew Brunswick, New Jersey 08901
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Solid Tumors
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Breast Cancer
188 reported clinical trials
8 medical researchers
Summary
Saint Peter's University Hospital is a medical facility located in New Brunswick, New Jersey. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Acute Lymphoblastic Leukemia, Breast Cancer and other specialties. Saint Peter's University Hospital is involved with conducting 188 clinical trials across 380 conditions. There are 8 research doctors associated with this hospital, such as Nibal A. Zaghloul, Gopal R. Desai, Lisa A. Hopkins, and Susan A. McManus.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage IV
RB positive
Stage I
Top PIs
Nibal A. ZaghloulSaint Peter's University Hospital8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
32 reported clinical trials
74 drugs studied
Gopal R. DesaiCapital Health Medical Center-Hopewell4 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
10 drugs studied
Lisa A. HopkinsSaint Peter's University Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
6 drugs studied
Susan A. McManusSaint Peter's University Hospital8 years of reported clinical research
Studies Mammogram
Studies Breast Cancer
2 reported clinical trials
6 drugs studied
Clinical Trials running at Saint Peter's University Hospital
Cancer
Testicular cancer
Wilms Tumor
Prostate Cancer
Lung Cancer
Neuroblastoma
Bladder Cancer
Breast Cancer
Pancreatic Cancer
Lymphoma
Radiation Therapy
for Cancer with Bone Metastasis
This phase III trial compares the effect of adding radiation therapy to usual care on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causing symptoms (asymptomatic). High-risk bone metastases are defined by their location (including hip, shoulder, long bones, and certain levels of the spine), or size (2 cm or larger). These bone metastases appear to be at higher risk of complications such as fracture, spinal cord compression, and/or pain warranting surgery or radiation treatment. Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. The total dose of radiation can be delivered in a single day or divided in smaller doses for up to 5 days of total treatment. Usual care for asymptomatic bone metastases may include drugs that prevent bone loss, in addition to the treatment for the primary cancer or observation (which means no treatment until symptoms appear). Evidence has shown that preventative radiation therapy may be effective in lowering the number of bone metastases-related complications, however, it is not known if this approach is superior to usual care. Adding radiation therapy to usual care may be more effective in preventing bone-related complications than usual care alone in cancer patients with asymptomatic high-risk bone metastases.
Recruiting2 awards Phase 37 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Health Information Collection
for Childhood Cancer
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Peter's University Hospital?
Saint Peter's University Hospital is a medical facility located in New Brunswick, New Jersey. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Acute Lymphoblastic Leukemia, Breast Cancer and other specialties. Saint Peter's University Hospital is involved with conducting 188 clinical trials across 380 conditions. There are 8 research doctors associated with this hospital, such as Nibal A. Zaghloul, Gopal R. Desai, Lisa A. Hopkins, and Susan A. McManus.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.